Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06266299
What this trial is testing

KK2269 in Adult Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Kyowa Kirin Co., Ltd. 101
Testing effectiveness (Phase 2)Study completedNCT03104699
What this trial is testing

AGEN2034 in Advanced Tumors and Cervical Cancer

Who this might be right for
Advanced CancerCervical Cancer
Agenus Inc. 211
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Early research (Phase 1)UnknownNCT05235438
What this trial is testing

Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor

Who this might be right for
OncologyCTLA4 Haploinsufficiency
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Very early researchLooking for participantsNCT05245058
What this trial is testing

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd 150
Early research (Phase 1)Study completedNCT01469052
What this trial is testing

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 36
Early research (Phase 1)Ended earlyNCT00811993
What this trial is testing

R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Hoffmann-La Roche 104
Early research (Phase 1)Study completedNCT00068484
What this trial is testing

A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT03017521
What this trial is testing

K-BASKET, TAS-117, PI3K/AKT Gene Aberration

Who this might be right for
Solid Tumor, Adult
Yonsei University 13
Early research (Phase 1)Study completedNCT01005355
What this trial is testing

Study of IMC-1121B in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 15
Not applicableLooking for participantsNCT07737509
What this trial is testing

Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis

Who this might be right for
Advanced Solid Tumours
Institute of Cancer Research, United Kingdom 5,000
Early research (Phase 1)Study completedNCT01225536
What this trial is testing

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

Who this might be right for
Solid Tumor
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07327411
What this trial is testing

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

Who this might be right for
Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University 40
Early research (Phase 1)WithdrawnNCT05655598
What this trial is testing

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Who this might be right for
Advanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more
Brown University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06736704
What this trial is testing

SNV4818 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pikavation Therapeutics, Inc. 320
Testing effectiveness (Phase 2)Looking for participantsNCT07805252
What this trial is testing

Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer

Who this might be right for
Advanced Solid Tumors Cancer
Orion Corporation, Orion Pharma 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Next Page